3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
2
Recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
1
Conditions
Carcinoma, Non-Small-Cell Lung
9
Breast Neoplasms
9
Head and Neck Neoplasms
6
Squamous Cell Carcinoma of Head and Neck
4
Neoplasms
4
Neoplasm Metastasis
4
Lung Neoplasms
4
Ovarian Neoplasms
3
Nasopharyngeal Carcinoma
3
Esophageal Squamous Cell Carcinoma
3
Colorectal Neoplasms
3
Anus Neoplasms
3
Urinary Bladder Neoplasms
2
Triple Negative Breast Neoplasms
2
Stomach Neoplasms
2
Rectal Neoplasms
2
Pancreatic Neoplasms
2
Oropharyngeal Neoplasms
2
Fallopian Tube Neoplasms
2
Esophageal Neoplasms
2
Small Cell Lung Carcinoma
1
Skin Neoplasms
1
Select Advanced Solid Tumors
1
SCLC, Extensive Stage
1
SCLC
1
Retinoblastoma
1
Retinal Neoplasms
1
Recurrence
1
Radiation Therapy
1
Prostatic Neoplasms
1
Interventions
Vincristine
3
Etoposide
3
Carboplatin
3
Cyclophosphamide
2
trioctyl phosphine oxide
1
pembrolizumab
1
pegfilgrastim
1
Topotecan
1
Thiotepa
1
Surveys and Questionnaires
1
Platinum Compounds
1
Observation
1
Mesna
1
Melphalan
1
Lasers, Semiconductor
1
Lasers
1
Granulocyte Colony-Stimulating Factor
1
Filgrastim
1
Eye Enucleation
1
Drug Therapy
1
Doxorubicin
1
Cytapheresis
1
Cryotherapy
1
Brachytherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Retinoblastoma
×
Drug Therapy
×
Clear all
NCT02866136
2025-11-24
RETINO2011
Institut Curie
Phase 2
Active not recruiting
133 enrolled